|
1
|
Van Nyen T, Moiola CP, Colas E, Annibali D
and Amant F: Modeling endometrial cancer: Past, present, and
future. Int J Mol Sci. 19:E23482018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackson RJ, Hellen CU and Pestova TV: The
mechanism of eukaryotic translation initiation and principles of
its regulation. Nat Rev Mol Cell Biol. 11:113–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Benedetti A and Graff JR: eIF-4E
expression and its role in malignancies and metastases. Oncogene.
23:3189–3199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pettersson F, Yau C, Dobocan MC,
Culjkovic-Kraljacic B, Retrouvey H, Puckett R, Flores LM, Krop IE,
Rousseau C, Cocolakis E, et al: Ribavirin treatment effects on
breast cancers overexpressing eIF4E, a biomarker with prognostic
specificity for luminal B-type breast cancer. Clin Cancer Res.
17:2874–2884. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berkel HJ, Turbat-Herrera EA, Shi R and de
Benedetti A: Expression of the translation initiation factor eIF4E
in the polyp-cancer sequence in the colon. Cancer Epidemiol
Biomarkers Prev. 10:663–666. 2001.PubMed/NCBI
|
|
7
|
Choi CH, Lee JS, Kim SR, Lee YY, Kim CJ,
Lee JW, Kim TJ, Lee JH, Kim BG and Bae DS: Direct inhibition of
eIF4E reduced cell growth in endometrial adenocarcinoma. J Cancer
Res Clin Oncol. 137:463–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith KA, Zhou B, Avdulov S, Benyumov A,
Peterson M, Liu Y, Okon A, Hergert P, Braziunas J, Wagner CR, et
al: Transforming growth factor-β1 induced epithelial mesenchymal
transition is blocked by a chemical antagonist of translation
factor eIF4E. Sci Rep. 5:182332015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spaderna S, Schmalhofer O, Wahlbuhl M,
Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A,
et al: The transcriptional repressor ZEB1 promotes metastasis and
loss of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Xie Y, Cui D, Ma Y, Sui L, Zhu C,
Kong H and Kong Y: Osteopontin promotes invasion, migration and
epithelial-mesenchymal transition of human endometrial carcinoma
cell HEC-1A through AKT and ERK1/2 signaling. Cell Physiol Biochem.
37:1503–1512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aparicio LA, Abella V, Valladares M and
Figueroa A: Posttranscriptional regulation by RNA-binding proteins
during epithelial-to-mesenchymal transition. Cell Mol Life Sci.
70:4463–4477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He M and Xue Y: MicroRNA-148a suppresses
proliferation and invasion potential of non-small cell lung
carcinomas via regulation of STAT3. Onco Targets Ther.
10:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang HH, Pang M, Dong W, Xin JX, Li YJ,
Zhang ZC, Yu L, Wang PY, Li BS and Xie SY: miR-511 induces the
apoptosis of radioresistant lung adenocarcinoma cells by triggering
BAX. Oncol Rep. 31:1473–1479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J,
Jiang Z, Zhang Y, Chen M, Chen P, et al: MiR-320a-3p/ELF3 axis
regulates cell metastasis and invasion in non-small cell lung
cancer via PI3K/Akt pathway. Gene. 670:31–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ge X, Cui H, Zhou Y, Yin D, Feng Y, Xin Q,
Xu X, Liu W, Liu S and Zhang Q: miR-320a modulates cell growth and
chemosensitivity via regulating ADAM10 in gastric cancer. Mol Med
Rep. 16:9664–9670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu X, Tang H, Liu G, Wang H, Shu J and Sun
F: miR-448 suppressed gastric cancer proliferation and invasion by
regulating ADAM10. Tumour Biol. 37:10545–10551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang
Y, Ma R, Jiang YH and Sun NF: MicroRNA-199b-5p attenuates
TGF-β1-induced epithelial-mesenchymal transition in hepatocellular
carcinoma. Br J Cancer. 117:233–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Y, Luo W, Yang ZJ, Chi JR, Li YR, Ding
Y, Ge J, Wang X and Cao XC: miR-190 suppresses breast cancer
metastasis by regulation of TGF-β-induced epithelial-mesenchymal
transition. Mol Cancer. 17:702018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
24
|
Sepramaniam S, Armugam A, Lim KY, Karolina
DS, Swaminathan P, Tan JR and Jeyaseelan K: MicroRNA 320a functions
as a novel endogenous modulator of aquaporins 1 and 4 as well as a
potential therapeutic target in cerebral ischemia. J Biol Chem.
285:29223–29230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P,
Zhang Q, Dong L, Liu Y and Dong J: microRNA-320a inhibits tumor
invasion by targeting neuropilin 1 and is associated with liver
metastasis in colorectal cancer. Oncol Rep. 27:685–694.
2012.PubMed/NCBI
|
|
26
|
Sun JY, Huang Y, Li JP, Zhang X, Wang L,
Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, et al: MicroRNA-320a
suppresses human colon cancer cell proliferation by directly
targeting β-catenin. Biochem Biophys Res Commun. 420:787–792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao H, Yu L, Li F, Wang H, Li W and He X:
MiR-340 suppresses the metastasis by targeting EphA3 in cervical
cancer. Cell Biol Int. 42:1115–1123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi S, Chen X, Liu H, Yu K, Bao Y, Chai J,
Gao H and Zou L: LGR5 acts as a target of miR-340-5p in the
suppression of cell progression and drug resistance in breast
cancer via Wnt/β-catenin pathway. Gene. 683:47–53. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Graff JR, Konicek BW, Carter JH and
Marcusson EG: Targeting the eukaryotic translation initiation
factor 4E for cancer therapy. Cancer Res. 68:631–634. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi ZM, Liu YN, Fu B, Shen YF and Li LM:
Expression profile of eukaryotic translation initiation factor and
matrix metalloproteinase 9 in endometrial cancer tissue. J Biol
Regul Homeost Agents. 31:1053–1059. 2017.PubMed/NCBI
|
|
31
|
Mannelqvist M, Stefansson IM, Bredholt G,
Hellem Bø T, Oyan AM, Jonassen I, Kalland KH, Salvesen HB and
Akslen LA: Gene expression patterns related to vascular invasion
and aggressive features in endometrial cancer. Am J Pathol.
178:861–871. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Konicek BW, Dumstorf CA and Graff JR:
Targeting the eIF4F translation initiation complex for cancer
therapy. Cell Cycle. 7:2466–2471. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karahan N, Guney M, Baspinar S, Oral B,
Kapucuoglu N and Mungan T: Expression of gelatinase (MMP-2 and
MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J
Gynaecol Oncol. 28:184–188. 2007.PubMed/NCBI
|
|
34
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Robichaud N, del Rincon SV, Huor B, Alain
T, Petruccelli LA, Hearnden J, Goncalves C, Grotegut S, Spruck CH,
Furic L, et al: Phosphorylation of eIF4E promotes EMT and
metastasis via translational control of SNAIL and MMP-3. Oncogene.
34:2032–2042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vega S, Morales AV, Ocaña OH, Valdes F,
Fabregat I and Nieto MA: Snail blocks the cell cycle and confers
resistance to cell death. Genes Dev. 18:1131–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dragomirescu M, Stepan AE, Margaritescu C
and Simionescu CE: The immunoexpression of p53 and snail in
endometrioid endometrial carcinomas. Rom J Morphol Embryol.
59:131–137. 2018.PubMed/NCBI
|
|
38
|
Xiong S, Klausen C, Cheng JC and Leung PC:
Activin B promotes endometrial cancer cell migration by
down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL
signaling. Oncotarget. 7:40060–40072. 2016. View Article : Google Scholar : PubMed/NCBI
|
